James Bauersmith

James Bauersmith

Directeur/Membre du Conseil chez LANNETT COMPANY, INC.
Health Technology
Consumer Services
Health Services

Profil

Mr. James Bauersmith is a Vice President, Translational Sciences at UPMC Enterprises.
He is on the Board of Directors at Lannett Co., Inc. Mr. Bauersmith was previously employed as a Chief Strategy Officer & General Counsel by Second Science Inc, a SVP Head of Corporate Development & Procurement by Amneal NewCo, Inc., and a SVP, Head of Global Drug Portfolio Strategy by Fresenius SE & Co. KGaA. He also served on the board at Akorn, Inc. He received his undergraduate degree from the University of Notre Dame, a graduate degree from Drexel University and a graduate degree from The Pennsylvania State University.

Postes actifs de James Bauersmith

SociétésPosteDébut
LANNETT COMPANY, INC. Directeur/Membre du Conseil -
Corporate Officer/Principal 01/08/2021

Anciens postes connus de James Bauersmith

SociétésPosteFin
Conseiller Juridique Général 01/10/2021
AMNEAL PHARMACEUTICALS, INC. Corporate Officer/Principal 30/06/2019
FRESENIUS SE & CO. KGAA Corporate Officer/Principal 31/05/2018
AKORN, INC. Directeur/Membre du Conseil -
Voir l'expérience en détail de James Bauersmith

Formation de James Bauersmith

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

95

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Non-Durables

Health Technology

  1. Bourse
  2. Insiders
  3. James Bauersmith
🔇